Science v. Ideology in Court: Mifepristone and the U.S. Food and Drug Administration | Annals of Internal Medicine
This commentary discusses the implications of a recent Texas federal district court ruling that halted the nationwide marketing of mifepristone. Not only will this ruling affect access to a safe an…